期刊文献+

血液系统肿瘤患者外周血细胞IgH基因和TCRγ基因的检测及意义 被引量:2

The Significance of Detecting the Clonal Rearrangements of Immunoglobulin Heavy Chain Gene and T cell Receptor γ Gene in Peripheral Blood Cells of Patients with Hemapoietic Malignancies
原文传递
导出
摘要 检测各种血液系统肿瘤患者外周血细胞免疫球蛋白重链基因 (IgH )和T细胞受体γ基因 (TCRγ )克隆性重排并探讨其意义。通过多聚酶链式反应 (PCR )方法检测 32例非霍奇金淋巴瘤 (NHL )、 18例急性髓性白血病 (AML )、 2 4例多发性骨髓瘤 (MM )、 8例急性淋巴细胞白血病 (ALL )及 6例慢性淋巴细胞白血病 (CLL )患者外周血细胞IgH及TCRγ克隆性基因重排。结果表明 ,NHL、AML、MM、ALL及CLL患者中IgH克隆性重排率分别为 37 5 0 %、 2 2 2 2 %、 83 33%、 12 5 0 %和 16 6 7% ;TCRγ基因克隆性重排率分别为 6 2 5 0 %、 5 0 0 0 %、 5 4 17%、 5 0 0 0 %及 5 0 0 0 %。在B型、T型NHL中 ,IgH克隆性重排率分别为 31 5 8%及 6 6 6 7% ;TCRγ克隆性重排率分别为 47 37%及 6 6 6 7%。AML中IgH克隆性重排阳性者的初治完全缓解率(CR ) (5 0 0 0 % )与IgH重排阴性的初治CR率 (5 0 0 0 % )无显著差异 (P >0 0 5 )。TCRγ克隆性重排阳性者与阴性者的初治CR率 (均为 44 44 % )亦无显著差异 (P >0 0 5 )。IgH及TCRγ基因克隆性重排不具有细胞谱系的特异性 ,但通过检测外周血IgH、TCRγ克隆性基因重排对NHL有辅助诊断意义 ,并且可作为监测微小残留病壮 (MRD )的手段。 To investigate the clonal rearrangements of immunoglobulin heavy chain gene (IgH) and T cell receptor γ gene (TCRγ) in peripheral blood cells of patients with hemapoietic malignancies and their significance,the clonal rearrangements of IgH and TCRγ genes were detected by polymerase chain reaction (PCR) in peripheral blood cells of patients with hemapoietic malignancies,including 32 cases of non Hodgkin lymphoma (NHL),18 cases of acute myeloid leukemia (AML),24 cases of multiple myeloma (MM),8 cases of acute lymphoblastic leukemia (ALL) and 6 cases of chronic lymphoblastic leukemia (CLL) In patients with NHL,AML,MM,ALL and CLL,the IgH gene clonal rearrangement rates were 37 50%,22 22%,83 33%,12 50% and 16 67% respectively,and the TCRγ gene clonal rearrangement rates were 62 50%,50 00%,54 17%,50 00% and 50 00% respectively In patients with T cell and B cell NHL,IgH gene clonal rearrangement rates were 31 58% and 66 67%,and TCRγ gene clonal rearrangement rates were 47 37% and 66 67% There was no obvious difference between those with IgH clonal rearrangement and those without IgH clonal rearrangement (P>0 05) and between those with TCRγ clonal rearrangement and those without TCRγ clonal rearrangement (P>0 05) in the complete remission rates after the first chemotherapy From these it con cludes the clonal rearrangements of IgH and TCRγ genes may have on lineage specificity,but detection of IgH and TCRγ gene clonal rearrangements in peripheral blood cells may be helpful in diagnosis of NHL and is an efficient method in surveillance of minimal residual disease (MRD) Key words hemapoietic malignancies;gene rearrangement;IgH;TCRγ CDE will take important role in detecting the cancer in early stage or studying its hemodynamics in future.
出处 《上海免疫学杂志》 CSCD 北大核心 2000年第2期113-115,共3页 Shanghai Journal of Immunology
关键词 血液系统肿瘤 基因重排 IGH TCRΓ liver neoplasms,experimental
  • 相关文献

参考文献1

同被引文献20

  • 1International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol, 2003,121: 749-757.
  • 2Blade J, Samson D, Reece D, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietie stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol, 1998, 102: 1115- 1123.
  • 3Bradwell AR. Serum free light chain analysis . 2nd ed. Birmingham: The binding site Ltd. , 2004: 13-21.
  • 4Bradwell AR. Serum free light chain analysis. 2nd ed. Birmingham: The binding site Ltd. , 2004: 49-60.
  • 5Bradwell AR. Serum free light chain measurements move to center stage. Clin Chem, 2005, 51:805-807.
  • 6Katzmann JA, Clark RJ, Abraham RS, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem, 2002, 48 : 1437-1444.
  • 7Duri BG, Harousseau JL, Miguel JS, et al. International uniform response criteria for multiple myeloma. Leukemia, 2006, 20, 1467-1473.
  • 8Drayson M, Tang LX, Drew R, et al. Serum free light-chain measurements for identifying and moritoring patients with nonseretory multiple myeloma. Blood, 2001, 97: 2900-2902.
  • 9Blade J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am, 1999, 13: 1259-1272.
  • 10Turesson I, Grubb A. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature. Acta Med Scand, 1978,204:445-451.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部